var singsData = [{"date":new Date(2012,1,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2012,1,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Charles Stanley downgrades CCL to Hold from Accumulate.","showOnAxis":true},{"date":new Date(2012,10,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2012,10,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $48; previously $46.","showOnAxis":true},{"date":new Date(2012,11,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CCL to Buy. Target Price is $47; previously $40.","showOnAxis":true},{"date":new Date(2012,11,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RS Platou Markets maintains CCL to Neutral. Target Price is $44; previously $38.","showOnAxis":true},{"date":new Date(2012,11,20),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2012 Q4's earning $0.13 per share and revenue $3580MM. This beats analyst's estimated EPS $0.11, beats estimated revenue $3540MM.","showOnAxis":false},{"date":new Date(2012,11,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains CCL to Neutral. Target Price is $38.5; previously $42.75.","showOnAxis":true},{"date":new Date(2012,11,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.5","showOnAxis":true},{"date":new Date(2012,2,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $30; previously $27.","showOnAxis":true},{"date":new Date(2012,2,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CCL to Buy. Target Price is $36; previously $39.","showOnAxis":true},{"date":new Date(2012,2,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CCL to Buy. Target Price is $34; previously $35.","showOnAxis":true},{"date":new Date(2012,2,9),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2012 Q1's earning $-0.18 per share and revenue $3582MM..","showOnAxis":false},{"date":new Date(2012,4,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2012,5,22),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2012 Q2's earning $0.2 per share and revenue $3500MM. This beats analyst's estimated EPS $0.08, misses estimated revenue $3550MM.","showOnAxis":false},{"date":new Date(2012,5,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CCL to Equal-Weight. Target Price is $38; previously $30.","showOnAxis":true},{"date":new Date(2012,5,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $34; previously $30.","showOnAxis":true},{"date":new Date(2012,5,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $41; previously $35.","showOnAxis":true},{"date":new Date(2012,5,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CCL to Buy. Target Price is $40; previously $39.","showOnAxis":true},{"date":new Date(2012,7,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2012,8,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CCL to Buy. Target Price is $38.5; previously $37.5.","showOnAxis":true},{"date":new Date(2012,8,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Topeka downgrades CCL to Hold from Buy. Target Price is $38.","showOnAxis":true},{"date":new Date(2012,8,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2012 Q3's earning $1.53 per share and revenue $4680MM. This beats analyst's estimated EPS $1.44, meets estimated revenue $4680MM.","showOnAxis":false},{"date":new Date(2012,8,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CCL to Buy. Target Price is $40; previously $38.5.","showOnAxis":true},{"date":new Date(2012,8,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CCL to Equal-Weight. Target Price is $36; previously $35.","showOnAxis":true},{"date":new Date(2012,8,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CCL to Buy. Target Price is $44; previously $42.","showOnAxis":true},{"date":new Date(2012,8,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies downgrades CCL to Hold from Buy. Target Price is $37.5.","showOnAxis":true},{"date":new Date(2012,8,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains CCL to Buy. Target Price is $42; previously $40.","showOnAxis":true},{"date":new Date(2012,8,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains CCL to Neutral. Target Price is $38; previously $35.","showOnAxis":true},{"date":new Date(2012,9,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays initiates coverage on CCL to Equal-Weight.","showOnAxis":true},{"date":new Date(2012,9,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $37; previously $34.","showOnAxis":true},{"date":new Date(2013,0,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains CCL to Buy. Target Price is $85; previously $75.","showOnAxis":true},{"date":new Date(2013,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CCL to Buy. Target Price is $43.37; previously $40.16.","showOnAxis":true},{"date":new Date(2013,1,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2013,1,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CCL to Neutral. Target Price is $35; previously $36.","showOnAxis":true},{"date":new Date(2013,10,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2013,11,19),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades CCL to Buy from Neutral.","showOnAxis":false},{"date":new Date(2013,11,19),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2013 Q4's earning $0.09 per share and revenue $3658MM..","showOnAxis":false},{"date":new Date(2013,11,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Credit Suisse upgrades CCL to Outperform from Neutral. Target Price is $43; previously $30.","showOnAxis":false},{"date":new Date(2013,11,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Natixis upgrades CCL to Neutral from Reduce.","showOnAxis":false},{"date":new Date(2013,11,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains CCL to Neutral. Target Price is $36; previously $32.","showOnAxis":true},{"date":new Date(2013,11,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $43; previously $41.","showOnAxis":true},{"date":new Date(2013,11,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $41; previously $42.","showOnAxis":true},{"date":new Date(2013,2,15),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2013 Q1's earning $0.08 per share and revenue $3590MM. This beats analyst's estimated EPS $0.02, misses estimated revenue $3630MM.","showOnAxis":false},{"date":new Date(2013,2,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CCL to Neutral. Target Price is $34; previously $35.","showOnAxis":true},{"date":new Date(2013,2,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CCL to Buy. Target Price is $42; previously $47.","showOnAxis":true},{"date":new Date(2013,2,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Exane BNP Paribas downgrades CCL to Neutral from Outperform.","showOnAxis":true},{"date":new Date(2013,2,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains CCL to Neutral. Target Price is $35; previously $38.5.","showOnAxis":true},{"date":new Date(2013,2,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains CCL to Buy. Target Price is $42; previously $46.","showOnAxis":true},{"date":new Date(2013,2,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CCL to Buy. Target Price is $40; previously $44.","showOnAxis":true},{"date":new Date(2013,3,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura downgrades CCL to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CCL to Neutral from Neutral. Target Price is $32; previously $34.","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"HSBC downgrades CCL to Neutral from Market Outperform. Target Price is $37.5; previously $44.","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains CCL to Neutral. Target Price is $36; previously $37.5.","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RS Platou Markets maintains CCL to Neutral. Target Price is $33; previously $38.","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $40; previously $43.","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS downgrades CCL to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wells Fargo downgrades CCL to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2013,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"William Blair downgrades CCL to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2013,4,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2013,4,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CCL to Buy. Target Price is $40; previously $42.","showOnAxis":true},{"date":new Date(2013,4,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"HSBC downgrades CCL to Neutral from Overweight.","showOnAxis":true},{"date":new Date(2013,4,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Exane BNP Paribas downgrades CCL to Underperform from Neutral.","showOnAxis":true},{"date":new Date(2013,5,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Numis Securities upgrades CCL to Buy from Add.","showOnAxis":false},{"date":new Date(2013,5,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2013 Q2's earning $0.09 per share and revenue $3500MM. This beats analyst's estimated EPS $0.06, misses estimated revenue $3560MM.","showOnAxis":false},{"date":new Date(2013,5,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $44; previously $40.","showOnAxis":true},{"date":new Date(2013,6,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Numis Securities downgrades CCL to Add from Buy.","showOnAxis":true},{"date":new Date(2013,7,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades CCL to Buy from Neutral. Target Price is $42; previously $31.","showOnAxis":false},{"date":new Date(2013,7,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Tigress Financial initiates coverage on CCL to Underperform.","showOnAxis":true},{"date":new Date(2013,7,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2013,8,24),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2013 Q3's earning $1.38 per share and revenue $4730MM. This beats analyst's estimated EPS $1.3, beats estimated revenue $4650MM.","showOnAxis":false},{"date":new Date(2013,8,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America downgrades CCL to Neutral from Buy. Target Price is $38.5; previously $42.8.","showOnAxis":true},{"date":new Date(2013,8,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CCL to Buy. Target Price is $39; previously $40.","showOnAxis":true},{"date":new Date(2013,8,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains CCL to Buy. Target Price is $40; previously $44.","showOnAxis":true},{"date":new Date(2013,8,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley downgrades CCL to Underweight from Equal-Weight. Target Price is $32.","showOnAxis":true},{"date":new Date(2013,8,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Natixis downgrades CCL to Reduce from Neutral.","showOnAxis":true},{"date":new Date(2013,8,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains CCL to Neutral. Target Price is $32; previously $36.","showOnAxis":true},{"date":new Date(2013,8,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Numis Securities downgrades CCL to Hold from Add.","showOnAxis":true},{"date":new Date(2013,8,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $42; previously $44.","showOnAxis":true},{"date":new Date(2013,8,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Susquehanna upgrades CCL to Positive from Neutral.","showOnAxis":false},{"date":new Date(2013,9,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey initiates coverage on CCL to Reduce. Target Price is $26.","showOnAxis":true},{"date":new Date(2014,0,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"SunTrust Robinson Humphrey upgrades CCL to Neutral from Reduce.","showOnAxis":false},{"date":new Date(2014,0,28),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Numis Securities upgrades CCL to Buy from Hold.","showOnAxis":false},{"date":new Date(2014,1,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies downgrades CCL to Underperform from Hold. Target Price is $33; previously $31.","showOnAxis":true},{"date":new Date(2014,1,19),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2014,1,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $48; previously $43.","showOnAxis":true},{"date":new Date(2014,1,5),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"HSBC upgrades CCL to Overweight from Neutral. Target Price is $43.5; previously $33.","showOnAxis":false},{"date":new Date(2014,10,19),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2014,11,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs downgrades CCL to Neutral from Buy.","showOnAxis":true},{"date":new Date(2014,11,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CCL to Buy. Target Price is $48; previously $46.","showOnAxis":true},{"date":new Date(2014,11,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $54; previously $52.","showOnAxis":true},{"date":new Date(2014,11,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America maintains CCL to Buy. Target Price is $53; previously $49.","showOnAxis":true},{"date":new Date(2014,11,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CCL to Underperform. Target Price is $36; previously $33.","showOnAxis":true},{"date":new Date(2014,2,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $49; previously $48.","showOnAxis":true},{"date":new Date(2014,2,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2014 Q1's earning $0 per share and revenue $3585MM. This beats analyst's estimated EPS $-0.08, beats estimated revenue $3560MM.","showOnAxis":false},{"date":new Date(2014,2,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America maintains CCL to Neutral. Target Price is $42.9; previously $43.6.","showOnAxis":true},{"date":new Date(2014,2,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CCL to Neutral. Target Price is $39; previously $38.","showOnAxis":true},{"date":new Date(2014,3,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Berenberg initiates coverage on CCL to Buy. Target Price is $50.","showOnAxis":true},{"date":new Date(2014,4,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades CCL to Equal-weight from Underweight.","showOnAxis":false},{"date":new Date(2014,4,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2014,5,23),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2014 Q2's earning $0.1 per share and revenue $3630MM. This beats analyst's estimated EPS $0.02, beats estimated revenue $3610MM.","showOnAxis":false},{"date":new Date(2014,7,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2014,7,7),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bank of America upgrades CCL to Buy from Neutral.","showOnAxis":false},{"date":new Date(2014,8,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Shore Capital upgrades CCL to Buy from Hold.","showOnAxis":false},{"date":new Date(2014,8,23),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2014 Q3's earning $1.58 per share and revenue $4950MM. This beats analyst's estimated EPS $1.44, beats estimated revenue $4930MM.","showOnAxis":false},{"date":new Date(2014,8,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America maintains CCL to Buy. Target Price is $49; previously $45.5.","showOnAxis":true},{"date":new Date(2014,8,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CCL to Outperform. Target Price is $46; previously $43.","showOnAxis":true},{"date":new Date(2014,8,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $52; previously $49.","showOnAxis":true},{"date":new Date(2015,0,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Natixis downgrades CCL to Neutral from Buy.","showOnAxis":true},{"date":new Date(2015,1,18),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2015,10,18),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.3","showOnAxis":true},{"date":new Date(2015,10,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"HSBC initiates coverage on CCL to Buy. Target Price is $60.","showOnAxis":true},{"date":new Date(2015,10,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Buckingham Research maintains CCL to Buy. Target Price is $60; previously $65.","showOnAxis":true},{"date":new Date(2015,11,18),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2015 Q4's earning $0.5 per share and revenue $3711MM. This beats analyst's estimated EPS $0.42, misses estimated revenue $3720MM.","showOnAxis":false},{"date":new Date(2015,11,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CCL to Equal-Weight. Target Price is $57; previously $54.","showOnAxis":true},{"date":new Date(2015,11,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey maintains CCL to Buy. Target Price is $59; previously $55.","showOnAxis":true},{"date":new Date(2015,2,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wedbush initiates coverage on CCL to Neutral. Target Price is $52.","showOnAxis":true},{"date":new Date(2015,2,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank downgrades CCL to Hold from Buy. Target Price is $51; previously $48.","showOnAxis":true},{"date":new Date(2015,2,30),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Numis Securities upgrades CCL to Add from Hold.","showOnAxis":false},{"date":new Date(2015,2,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CCL to Outperform. Target Price is $55; previously $52.","showOnAxis":true},{"date":new Date(2015,3,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey maintains CCL to Neutral. Target Price is $53; previously $52.","showOnAxis":true},{"date":new Date(2015,3,29),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Tigress Financial upgrades CCL to Neutral from Underperform.","showOnAxis":false},{"date":new Date(2015,3,7),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Wells Fargo upgrades CCL to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2015,4,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"SunTrust Robinson Humphrey upgrades CCL to Buy from Neutral.","showOnAxis":false},{"date":new Date(2015,4,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2015,5,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Susquehanna maintains CCL to Positive. Target Price is $56; previously $55.","showOnAxis":true},{"date":new Date(2015,5,22),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades CCL to Buy from Hold. Target Price is $55.3; previously $51.","showOnAxis":false},{"date":new Date(2015,5,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Buckingham Research maintains CCL to Buy. Target Price is $60; previously $58.","showOnAxis":true},{"date":new Date(2015,5,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $60; previously $55.","showOnAxis":true},{"date":new Date(2015,5,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey maintains CCL to Buy. Target Price is $55; previously $53.","showOnAxis":true},{"date":new Date(2015,6,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Jefferies upgrades CCL to Hold from Underperform.","showOnAxis":false},{"date":new Date(2015,6,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CCL to Buy. Target Price is $58; previously $56.","showOnAxis":true},{"date":new Date(2015,7,19),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.3","showOnAxis":true},{"date":new Date(2015,8,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CCL to Equal-Weight. Target Price is $53; previously $48.","showOnAxis":true},{"date":new Date(2015,8,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Susquehanna maintains CCL to Positive. Target Price is $60; previously $56.","showOnAxis":true},{"date":new Date(2015,8,23),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Nomura upgrades CCL to Buy from Neutral. Target Price is $62; previously $53.","showOnAxis":false},{"date":new Date(2015,8,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CCL to Buy. Target Price is $61; previously $60.","showOnAxis":true},{"date":new Date(2015,9,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CCL to Buy. Target Price is $57; previously $58.","showOnAxis":true},{"date":new Date(2016,0,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CCL to Buy. Target Price is $60; previously $55.3.","showOnAxis":true},{"date":new Date(2016,1,17),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.3","showOnAxis":true},{"date":new Date(2016,1,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse assumes CCL to Outperform. Target Price is $60.","showOnAxis":true},{"date":new Date(2016,10,22),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":null,"showOnAxis":false},{"date":new Date(2016,10,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2016,10,23),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bernstein upgrades CCL to Outperform from Market Perform. Target Price is $63; previously $52.","showOnAxis":false},{"date":new Date(2016,11,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs initiates coverage on CCL to Neutral.","showOnAxis":true},{"date":new Date(2016,11,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Berenberg downgrades CCL to Hold from Buy.","showOnAxis":true},{"date":new Date(2016,11,20),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2016 Q4's earning $0.67 per share and revenue $3935MM..","showOnAxis":false},{"date":new Date(2016,2,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains CCL to Neutral. Target Price is $52.5; previously $49.5.","showOnAxis":true},{"date":new Date(2016,2,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CCL to Equal-Weight. Target Price is $58; previously $57.","showOnAxis":true},{"date":new Date(2016,2,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains CCL to Neutral. Target Price is $53.5; previously $52.5.","showOnAxis":true},{"date":new Date(2016,2,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CCL to Neutral. Target Price is $58; previously $57.","showOnAxis":true},{"date":new Date(2016,2,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey maintains CCL to Buy. Target Price is $60; previously $59.","showOnAxis":true},{"date":new Date(2016,3,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CCL to Buy. Target Price is $60; previously $58.","showOnAxis":true},{"date":new Date(2016,3,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CCL to Buy. Target Price is $60; previously $58.","showOnAxis":true},{"date":new Date(2016,4,25),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2016,4,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $54; previously $60.","showOnAxis":true},{"date":new Date(2016,4,31),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Tigress Financial upgrades CCL to Buy from Neutral.","showOnAxis":false},{"date":new Date(2016,5,28),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2016 Q2's earning $0.49 per share and revenue $3705MM. This beats analyst's estimated EPS $0.38, beats estimated revenue $3680MM.","showOnAxis":false},{"date":new Date(2016,5,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains CCL to Neutral. Target Price is $52; previously $46.5.","showOnAxis":true},{"date":new Date(2016,5,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Sterne Agee CRT initiates coverage on CCL to Buy. Target Price is $60.","showOnAxis":true},{"date":new Date(2016,7,24),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.35","showOnAxis":true},{"date":new Date(2016,8,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley downgrades CCL to Underweight from Equal-Weight. Target Price is $48; previously $54.","showOnAxis":true},{"date":new Date(2016,8,26),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CCL reports 2016 Q3's earning $1.92 per share and revenue $5097MM. This beats analyst's estimated EPS $1.88, beats estimated revenue $5060MM.","showOnAxis":false},{"date":new Date(2016,8,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Buckingham Research maintains CCL to Buy. Target Price is $55; previously $53.","showOnAxis":true},{"date":new Date(2016,8,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank initiates coverage on CCL to Hold. Target Price is $48.","showOnAxis":true},{"date":new Date(2016,8,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bernstein initiates coverage on CCL to Outperform. Target Price is $51.","showOnAxis":true},{"date":new Date(2016,9,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"HSBC initiates coverage on CCL to Buy. Target Price is $60.","showOnAxis":true},{"date":new Date(2016,9,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie initiates coverage on CCL to Neutral.","showOnAxis":true}];